Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T therapy
214 employees · est. 2017 · South San Francisco, United...
FibroGen, Inc.
Committed to being a place where our people and science thrive.
347 employees · est. 1993 · San Francisco, United States
FibroGen, Inc. is the older company (2017 vs 1993).
Side-by-Side Comparison
| Metric | Allogene Therapeutics | FibroGen, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2017 | 1993 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | San Francisco, United States |
| Employees | ||
| Employees | 214 | 347 |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | IPO | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $1.05B | $308.02M |
| Funding Rounds | ||
| Funding Rounds | 4 | 7 |
| Services | ||
| Services | Development of CAR T cell products, Clinical trial management, Gene editing and engineering, Manufacturing of allogeneic therapies, Therapeutic innovation for cancer and autoimmune diseases | R&D Pipeline Management, Clinical Trials Execution, Drug Development, Scientific Research and Innovation |
| Target Customers | ||
| Target Customers | Patients with blood cancers, Patients with solid tumors, Patients with autoimmune diseases, Healthcare providers, Biopharmaceutical partners | Healthcare Providers, Medical Researchers, Pharmaceutical Investors, Patients with Prostate Cancer, Patients with Anemia |
| Taxonomy | ||
| Taxonomy | Clinical-stage, Cancer Treatment, Immunotherapy, CAR T Therapy, AlloCAR T Products, Allogeneic Therapies, Oncology, Autoimmune Disease, Cell Therapy, Therapy Development, Biopharmaceuticals, Medical Innovation, South San Francisco | Connective Tissue Growth Factor, Hypoxia-Inducible Factor Biology, Monoclonal Antibodies, HIF-PH Inhibitors, Anemia Treatment, Fibrotic Disease, Cancer Therapeutics, Pancreatic Cancer Treatment, Duchenne Muscular Dystrophy, Immuno-Oncology, Autoimmune Disorders, Biotechnology Research, Drug Development, Clinical Development |
| Website | ||
| Website | allogene.com | fibrogen.com |
About Allogene Therapeutics
Allogene Therapeutics, based in South San Francisco, is a clinical-stage biotechnology company spearheading the evolution of cancer treatment with its innovative AlloCAR T products. Founded in 2017, the company is at the forefront of developing allogeneic chimeric antigen receptor T cell therapies,...
About FibroGen, Inc.
FibroGen, Inc., founded in 1993, is a United States-based company operating in the biopharma and biotechnology sectors. The company is dedicated to pioneering first-in-class therapeutics targeting significant unmet medical needs globally, with a focus on areas such as anemia, fibrotic disease, and c...
We will tell you when either one moves
BounceWatch watches Allogene Therapeutics and FibroGen, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Allogene Therapeutics and FibroGen, Inc. — by email.
Frequently Asked Questions
Compare Allogene Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Allogene Therapeutics on 9 Jun 2026, and FibroGen, Inc. on 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.